Showing results (41-50 of 113) with videos related to
Sort By:
Pageof 12
Alcohol and Alcoholism (Oxford, Oxfordshire)|October 7, 2000
The long-term cost-effectiveness of improving alcohol abstinence with adjuvant acamprosateA J Palmer, K Neeser, C Weiss, et al.Occupational Medicine (Oxford, England)|November 17, 2015
Australian insurance costs of jockeys injured in a race-day fallB A Curry, P L Hitchens, P Otahal, et al.Diabetes Research and Clinical Practice|November 18, 2000
Outline of a diabetes disease management model: principles and applicationsA J Palmer, A Brandt, V Gozzoli, et al.Deutsche Medizinische Wochenschrift (1946)|January 3, 2004
[Health economic consequences of the use of irbesartan in patients in Germany with type 2 diabetes, nephropathy and hypertension]A J Palmer, L Annemans, S Roze, et al.Journal of Clinical Epidemiology|October 1, 1996
Use of surrogate respondents in studies of stroke and dementiaA Weiss, A E Fletcher, A J Palmer, et al.Obesity Reviews : an Official Journal of the International Association for the Study of Obesity|July 8, 2016
Diverse approaches to the health economic evaluation of bariatric surgery: a comprehensive systematic reviewJ A Campbell, A Venn, A Neil, et al.Diabetes Research and Clinical Practice|November 18, 2000
The Mt. Hood challenge: cross-testing two diabetes simulation modelsJ B Brown, A J Palmer, P Bisgaard, et al.Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|January 28, 2016
Screening for osteoporosis in Chinese post-menopausal women: a health economic modelling studyL Si, T M Winzenberg, M Chen, et al.Australian and New Zealand Journal of Medicine|October 1, 1979
The synergistic effect of weight loss and changes in dietary lipids on the serum cholesterol of obese men with hypercholesterolaemia: implications for prevention of coronary heart diseaseR B Blacket, B Leelarthaepin, C A McGilchrist, et al.Nefrologia : Publicacion Oficial De La Sociedad Espanola Nefrologia|July 31, 2004
[Cost-efectiveness of Ibersartan in type II diabetic nephropathy with hypertension. A Spanish perspective]A J Palmer, L Annemans, S Roze, et al.Pageof 12